chr1-27547334-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001371928.1(AHDC1):c.4782C>T(p.Pro1594=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.006 in 1,552,134 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0040 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0062 ( 42 hom. )
Consequence
AHDC1
NM_001371928.1 synonymous
NM_001371928.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.43
Genes affected
AHDC1 (HGNC:25230): (AT-hook DNA binding motif containing 1) This gene encodes a protein containing two AT-hooks, which likely function in DNA binding. Mutations in this gene were found in individuals with Xia-Gibbs syndrome. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 1-27547334-G-A is Benign according to our data. Variant chr1-27547334-G-A is described in ClinVar as [Benign]. Clinvar id is 783928.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.42 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00404 (615/152328) while in subpopulation NFE AF= 0.00657 (447/68036). AF 95% confidence interval is 0.00607. There are 3 homozygotes in gnomad4. There are 269 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 615 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AHDC1 | NM_001371928.1 | c.4782C>T | p.Pro1594= | synonymous_variant | 8/9 | ENST00000673934.1 | NP_001358857.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AHDC1 | ENST00000673934.1 | c.4782C>T | p.Pro1594= | synonymous_variant | 8/9 | NM_001371928.1 | ENSP00000501218 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00401 AC: 611AN: 152210Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
611
AN:
152210
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00392 AC: 778AN: 198486Hom.: 1 AF XY: 0.00381 AC XY: 405AN XY: 106194
GnomAD3 exomes
AF:
AC:
778
AN:
198486
Hom.:
AF XY:
AC XY:
405
AN XY:
106194
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00621 AC: 8695AN: 1399806Hom.: 42 Cov.: 30 AF XY: 0.00608 AC XY: 4203AN XY: 691522
GnomAD4 exome
AF:
AC:
8695
AN:
1399806
Hom.:
Cov.:
30
AF XY:
AC XY:
4203
AN XY:
691522
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00404 AC: 615AN: 152328Hom.: 3 Cov.: 33 AF XY: 0.00361 AC XY: 269AN XY: 74492
GnomAD4 genome
AF:
AC:
615
AN:
152328
Hom.:
Cov.:
33
AF XY:
AC XY:
269
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | AHDC1: BP4, BP7, BS1, BS2 - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 21, 2018 | - - |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at